Related Experiment Videos
Ventricular remodeling in heart failure
Mohamed A Gaballa1, Steven Goldman
1Cardiology Section, University of Arizona Sarver Heart Center, and the Southern Arizona VA Health Care System, Tucson, Arizona, USA.
Insights
This review covers left ventricular remodeling after heart attack and new strategies to reduce damage. Understanding these processes is key to developing better heart failure therapies.
Area of Science:
- Cardiology
- Pathophysiology
- Pharmacology
Background:
- Left ventricular (LV) remodeling is a key process in heart failure development after myocardial infarction.
- Existing therapies like ACE inhibitors and beta-blockers impact LV remodeling, improving mortality in heart failure patients.
- The rat infarct model accurately mimics human pathophysiology for studying heart failure.
Purpose of the Study:
- To review major mechanisms of LV remodeling post-myocardial infarction.
- To present novel strategies for limiting infarct size and retarding LV remodeling progression.
- To highlight the need for further research into the regression of ventricular remodeling.
Main Methods:
- Literature review of mechanisms and strategies for LV remodeling.
- Analysis of the rat infarct model's relevance to human heart failure.
- Discussion of current therapeutic impacts on LV remodeling.
Main Results:
- Major mechanisms of LV remodeling following myocardial infarction are highlighted.
- Novel strategies to limit infarct size and retard LV remodeling progression are presented.
- The favorable impact of certain interventions on LV remodeling is noted.
Conclusions:
- Understanding LV remodeling mechanisms is crucial for heart failure treatment.
- Further research into the regression of ventricular remodeling is needed.
- Investigating remodeling mechanisms may lead to new heart failure therapies.
Abstract:
This review briefly highlights the major mechanisms of left ventricular (LV) remodeling following myocardial infarction in heart failure and presents novel strategies to limit infarct size and retard the progression of LV remodeling. This is important since interventions that have been shown to improve mortality in patients with heart failure such as angiotensin converting enzyme inhibitor and beta-blockers had a favorable impact on the LV remodeling process. Although several other animal models of heart failure are available, we chose the rat infarct model because of its accurate reflection of human pathophysiology. It is clear from this review that the understanding of the mechanisms responsible for the regression of ventricular remodeling is still unclear. Further investigations in this area will certainly lead to the development of new therapy for heart failure.